Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

COVID-19 Resource Center

Featured

Editor in chief Winston Wong, PharmD.
Editor Insights
Looking at 2023 Key Trends and Insights to Navigate the Future of Value-Based Care
02/13/2024

Winston Wong, PharmD

Winston Wong, PharmD
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature...
02/13/2024
Journal of Clinical Pathways
News
The Ongoing Impact of COVID-19 on Caregivers of Patients With Chronic Lymphocytic Leukemia
03/15/2023

Grace Taylor

Grace Taylor
A recent study investigated the impact of COVID-19 on caregivers of patients with CLL during the post-vaccine phase of the pandemic and aimed to identify what resources are needed to better support these caregivers.
A recent study investigated the impact of COVID-19 on caregivers of patients with CLL during the post-vaccine phase of the pandemic and aimed to identify what resources are needed to better support these caregivers.
A recent study investigated the...
03/15/2023
Journal of Clinical Pathways
Research Reports
Post–COVID-19 Syndrome Clinical Pathway for the US Veterans Health Administration
02/06/2023
Claudia L Campos, MD
Cristina Nguyen, BS
Kristina Crothers, MD
Omar Awan, MD
Francis J Miller Jr, MD
Courtney Sedillo, MSN, FNP-C
Johnson Vachachira, NP
Carrie B May, PsyD
Allison M Gustavson, DPT, PhD
Jacob B Lindheimer, PhD
Lindheimer et al summarize the stepwise diagnostic approach for patients presenting with PCS dyspnea and/or cough in primary care and highlight teleconsultation and telerehabilitation as opportunities to reach those in rural areas or with...
Lindheimer et al summarize the stepwise diagnostic approach for patients presenting with PCS dyspnea and/or cough in primary care and highlight teleconsultation and telerehabilitation as opportunities to reach those in rural areas or with...
Lindheimer et al summarize the...
02/06/2023
Journal of Clinical Pathways
Research Reports
Treatment and Outcomes Among Hospitalized COVID-19 Patients With Immune-mediated Inflammatory Diseases: An Electronic Health Record Database Cohort Study
08/20/2021
Alex Z Fu, PhD
Qian Cai, MSPH, MS
Emily S Brouwer, MPH, PharmD PhD
Christopher D Pericone, PhD
Kimberly Woodruff, PharmD, PhD
Alex Z Fu, PhD, and colleagues explore treatment journeys and outcomes for hospitalized COVID-19 patients with rheumatoid arthritis, psoriatic arthritis, psoriasis, Crohn's disease, or ulcerative colitis.
Alex Z Fu, PhD, and colleagues explore treatment journeys and outcomes for hospitalized COVID-19 patients with rheumatoid arthritis, psoriatic arthritis, psoriasis, Crohn's disease, or ulcerative colitis.
Alex Z Fu, PhD, and colleagues...
08/20/2021
Journal of Clinical Pathways
Quiz: Are Patients With Cancer and COVID-19 at Higher Risk for Worse Outcomes?
04/13/2021
04/13/2021
Journal of Clinical Pathways
Conference Coverage
Digital Care Delivery Models and Staffing Concerns Amidst the COVID-19 Pandemic
03/03/2021
03/03/2021
Journal of Clinical Pathways
Cancer Care in 2021 and Beyond: Catalytic Trends, Entrants, and Developments to Optimize Care During and Post Pandemic
Cancer Care in 2021 and Beyond: Catalytic Trends, Entrants, and Developments to Optimize Care During and Post Pandemic
02/22/2021
Elizabeth Oyekan, PharmD, FCSHP, CPHQ
Health care has been traditionally immune to disruptive market forces until the COVID-19 global pandemic in 2020. This pandemic also highlighted the challenges and failings of our current health care system, creating...
Health care has been traditionally immune to disruptive market forces until the COVID-19 global pandemic in 2020. This pandemic also highlighted the challenges and failings of our current health care system, creating...
Health...
02/22/2021
Journal of Clinical Pathways
Positive Disruption in the COVID-19 Era: AMCCBS Virtual
02/22/2021
Association of Community Cancer Centers
The past year challenged cancer care professionals in ways that were seemingly unimaginable. With the spread of SARS-CoV-2 across the United States, cancer programs and practices were forced to dramatically change...
The past year challenged cancer care professionals in ways that were seemingly unimaginable. With the spread of SARS-CoV-2 across the United States, cancer programs and practices were forced to dramatically change...
The...
02/22/2021
Journal of Clinical Pathways
We Have Vaccines, Now What? How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access
We Have Vaccines, Now What? How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access
02/22/2021
Jason Shafrin, PhD
Marlon Graf, PhD
Rifat Tuly, MPH
Christoph Glaetzer, Dipl Kfm
Stacey Hickson, PhD
T Joseph Mattingly II, PhD, PharmD, MBA
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a catastrophic burden in both health and economic costs. Despite the December 2020 emergency use authorizations of two COVID-19 vaccines,...
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a catastrophic burden in both health and economic costs. Despite the December 2020 emergency use authorizations of two COVID-19 vaccines,...
...
02/22/2021
Journal of Clinical Pathways
Recognizing and Testing Telehealth Models in Oncology Care First
Quality Outlook
Recognizing and Testing Telehealth Models in Oncology Care First
02/09/2021

Tom Valuck, MD, JD—Blog Editor; David Blaisdell; Theresa Schmidt, MA, PMP, CSPO

Tom Valuck, MD, JD—Blog Editor; David...
In this blog, Tom Valuck, MD, JD, and colleagues explore ways for CMS to incorporate telehealth in oncology alternative payment models.
In this blog, Tom Valuck, MD, JD, and colleagues explore ways for CMS to incorporate telehealth in oncology alternative payment models.
In this blog, Tom Valuck, MD,...
02/09/2021
Journal of Clinical Pathways
News
Patients With Cancer and COVID-19 Infection are at a Higher Risk for Worse Outcomes
01/21/2021
01/21/2021
Journal of Clinical Pathways

Advertisement

News

News
The Ongoing Impact of COVID-19 on Caregivers of Patients With Chronic Lymphocytic Leukemia
03/15/2023

Grace Taylor

Grace Taylor
A recent study investigated the impact of COVID-19 on caregivers of patients with CLL during the post-vaccine phase of the pandemic and aimed to identify what resources are needed to better support these caregivers.
A recent study investigated the impact of COVID-19 on caregivers of patients with CLL during the post-vaccine phase of the pandemic and aimed to identify what resources are needed to better support these caregivers.
A recent study investigated the...
03/15/2023
Journal of Clinical Pathways
News
Patients With Cancer and COVID-19 Infection are at a Higher Risk for Worse Outcomes
01/21/2021
01/21/2021
Journal of Clinical Pathways
News
Use of Real-World EHR to Identify Disparities for COVID-19 in Patients With Cancer
01/05/2021
01/05/2021
Journal of Clinical Pathways
News
Impact of COVID-19-Related Social Distancing on Cancer Outcomes
01/05/2021
01/05/2021
Journal of Clinical Pathways
News
Consultation Recordings Support Shared Decision Making in Oncology During COVID-19 Pandemic
01/05/2021
01/05/2021
Journal of Clinical Pathways
News
Framework to Alleviate the Impact of the COVID-19 Pandemic on Patients With Cancer
01/05/2021
01/05/2021
Journal of Clinical Pathways
News
Medicare Telemedicine Reimbursement Before and After COVID-19
12/17/2020
A partnership between government agencies, clinicians, researchers, patient advocacy groups, and private-sector organizations needs to be created to rapidly test, evaluate, deploy, and pay for new telemedicine care models.
A partnership between government agencies, clinicians, researchers, patient advocacy groups, and private-sector organizations needs to be created to rapidly test, evaluate, deploy, and pay for new telemedicine care models.
A partnership between government...
12/17/2020
Journal of Clinical Pathways
News
Care Disparities Highlighted by COVID-19 Serve as “Wake-Up Call”
12/17/2020
12/17/2020
Journal of Clinical Pathways
News
Cancer Screenings, Diagnosis, and Treatments Decreased During COVID-19 Pandemic
11/03/2020
11/03/2020
Journal of Clinical Pathways
News
Impact of the COVID-19 Pandemic on Oncology Practice
10/09/2020
10/09/2020
Journal of Clinical Pathways
News
Patients With Breast Cancer Experience High Economic Burden and Lower HRQoL: Literature Review
05/15/2024
Grace Taylor, MS, MA
A systematic literature review summarizes the economic and health-related quality of life (HRQoL) outcomes experienced by patients with early-stage hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative...
A systematic literature review summarizes the economic and health-related quality of life (HRQoL) outcomes experienced by patients with early-stage hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative...
A systematic literature review...
05/15/2024
Journal of Clinical Pathways
News
The Economic Impact of Artificial Intelligence Usage in Screening Mammography
05/10/2024
Grace Taylor, MS, MA
Researchers evaluated the potential economic impact of artificial intelligence (AI) implementation on screening mammography from the perspective of treatment facilities and payers.
Researchers evaluated the potential economic impact of artificial intelligence (AI) implementation on screening mammography from the perspective of treatment facilities and payers.
Researchers evaluated the...
05/10/2024
Journal of Clinical Pathways
News
MorphoSys’ Myelofibrosis Drug Results Cast Doubt on Novartis Acquisition Deal
05/08/2024
Grace Taylor, MS, MA
MorphoSys’ $2.9 billion acquisition deal with Novartis may be in jeopardy due to reports regarding safety problems with its investigational myelofibrosis drug pelabresib.
MorphoSys’ $2.9 billion acquisition deal with Novartis may be in jeopardy due to reports regarding safety problems with its investigational myelofibrosis drug pelabresib.
MorphoSys’ $2.9 billion...
05/08/2024
Journal of Clinical Pathways
News
Dietary Recommendations for Patients With Myelofibrosis
04/22/2024

Grace Taylor

Grace Taylor
A balanced diet can help patients with myelofibrosis have more energy, better immune function, and more.
A balanced diet can help patients with myelofibrosis have more energy, better immune function, and more.
A balanced diet can help...
04/22/2024
Journal of Clinical Pathways
News
Study Estimates the Total Lifetime Cost of Treating Patients With CLL in the US
04/12/2024

Grace Taylor

Grace Taylor
A recent study by Farrukh Awan, MD, and colleagues estimated the total lifetime cost of treating patients with chronic lymphocytic leukemia in the US.
A recent study by Farrukh Awan, MD, and colleagues estimated the total lifetime cost of treating patients with chronic lymphocytic leukemia in the US.
A recent study by Farrukh Awan,...
04/12/2024
Journal of Clinical Pathways
News
Exploring Novel Therapies in Oncology: Lessons From the Oncology Care Model
04/11/2024

Brandon Twyford

Brandon Twyford
A study presented at the 2024 NCCN Annual Conference gives insight into care quality, cost dynamics, and the evolving landscape of oncologic innovation.
A study presented at the 2024 NCCN Annual Conference gives insight into care quality, cost dynamics, and the evolving landscape of oncologic innovation.
A study presented at the 2024...
04/11/2024
Journal of Clinical Pathways
News
Impact of Care Delays on Health Care Resource Utilization in Patients With Early-Stage Lung Cancer
04/11/2024

Brandon Twyford

Brandon Twyford
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on...
04/11/2024
Journal of Clinical Pathways
AI
News
The Potential for AI in Oncology
04/11/2024
Grace Taylor, MS, MA
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay...
04/11/2024
Journal of Clinical Pathways
News
Disease Progression for Patients With Low-Risk Myelofibrosis Participating in the MOST Study
03/26/2024

Grace Taylor

Grace Taylor
A group of researchers examined disease progression for patients with low-risk myelofibrosis participating in the prospective observational MOST study.
A group of researchers examined disease progression for patients with low-risk myelofibrosis participating in the prospective observational MOST study.
A group of researchers examined...
03/26/2024
Journal of Clinical Pathways
News
Rusfertide Treatment Strengthens Response and Decreases Erythrocytosis Among Patients With Polycythemia Vera
03/22/2024

Jordan Kadish

Jordan Kadish
According to findings from the phase 2 REVIVE trial, rusfertide treatment demonstrated improved responses and decreased erythrocytosis among patients with polycythemia vera.
According to findings from the phase 2 REVIVE trial, rusfertide treatment demonstrated improved responses and decreased erythrocytosis among patients with polycythemia vera.
According to findings from the...
03/22/2024
Oncology

Videos

Lalan Wilfong, MD
Videos
Balancing the Benefits and Risks of Value-Based Care Arrangements
05/16/2024
Lalan Wilfong, MD
Lalan Wilfong, MD, discusses his key takeaways from the Community Oncology Conference session on defining value-based care in oncology.
Lalan Wilfong, MD, discusses his key takeaways from the Community Oncology Conference session on defining value-based care in oncology.
Lalan Wilfong, MD, discusses his...
05/16/2024
Journal of Clinical Pathways
BDHC thumbnail
Breaking Down Health Care
The Bear: Why Does Health Care Cost So Much? (Part 1)
05/06/2024

Featuring Michael Kolodziej, MD, and John Hennessy, MBA

Featuring Michael Kolodziej, MD, and ...
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into two of the main stakeholders in health care costs: hospitals and health insurance companies. They discuss how these...
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into two of the main stakeholders in health care costs: hospitals and health insurance companies. They discuss how these...
In part one of this two-part...
05/06/2024
Cancer Care Business Exchange
Julia Morton
Videos
The Impact of Technology at the Point of Care in Community Practice
05/01/2024
Julia Morton, senior vice president and general manager at Flatiron Health, talks about how recent developments in technology have impacted point-of-care solutions in community oncology.
Julia Morton, senior vice president and general manager at Flatiron Health, talks about how recent developments in technology have impacted point-of-care solutions in community oncology.
Julia Morton, senior vice...
05/01/2024
Journal of Clinical Pathways
JCP Flatiron Roundtable 1 Thumbnail
Videos
Oncology Care Pathways: Perspectives on Strategies and Best Practices
05/01/2024

Featuring Gordon Kuntz; Jeremy Drainville; James Hamrick, MD; Larry Shulman, MD; Bryan Loy, MD

Featuring Gordon Kuntz; Jeremy Drainv...
In this roundtable, participants discuss how to develop and implement clinical pathways at cancer centers. This includes integrating both the latest clinical evidence and payer contract requirements to develop the most efficient clinical...
In this roundtable, participants discuss how to develop and implement clinical pathways at cancer centers. This includes integrating both the latest clinical evidence and payer contract requirements to develop the most efficient clinical...
In this roundtable, participants...
05/01/2024
Journal of Clinical Pathways
Michael Serzan, MD
Videos
Recent Advancements in the Treatment of Renal Cell Carcinoma
04/24/2024

Featuring Michael Serzan, MD, Dana-Farber Cancer Institute

Featuring Michael Serzan, MD, Dana-Fa...
Michael Serzan, MD, highlights some of the latest advancements in the treatment of renal cell carcinoma.
Michael Serzan, MD, highlights some of the latest advancements in the treatment of renal cell carcinoma.
Michael Serzan, MD, highlights...
04/24/2024
Journal of Clinical Pathways
Rose Gerber, MS
Videos
Becoming a Patient Advocate: Tips for Getting Started
04/12/2024

Featuring Rose Gerber, MS

Featuring Rose Gerber, MS
Patient advocate and cancer survivor Rose Gerber shares her experience in cancer patient advocacy and offers tips for those who wish to become advocates.
Patient advocate and cancer survivor Rose Gerber shares her experience in cancer patient advocacy and offers tips for those who wish to become advocates.
Patient advocate and cancer...
04/12/2024
Journal of Clinical Pathways
John Allan, MD, Weill Cornell Medicine
Conference Coverage
Comparing BTK Inhibitors for Frontline Chronic Lymphocytic Leukemia Treatment
04/10/2024

Featuring John Allan, MD

Featuring John Allan, MD
John Allan, MD, compares the use of different BTK inhibitors for the treatment of CLL in a frontline setting and discusses whether there is an optimal drug regimen to use among patients with CLL.
John Allan, MD, compares the use of different BTK inhibitors for the treatment of CLL in a frontline setting and discusses whether there is an optimal drug regimen to use among patients with CLL.
John Allan, MD, compares the use...
04/10/2024
Lymphoma, Leukemia & Myeloma Network
Erin Fox, PharmD
Videos
How Health Care Stakeholders in Oncology Can Prepare for and Manage Drug Shortages
04/08/2024

Featuring Erin Fox, PharmD

Featuring Erin Fox, PharmD
Erin Fox, PharmD, shares steps health care stakeholders can take to mitigate the impact of drug shortages on cancer care.
Erin Fox, PharmD, shares steps health care stakeholders can take to mitigate the impact of drug shortages on cancer care.
Erin Fox, PharmD, shares steps...
04/08/2024
Journal of Clinical Pathways
Robert Stillman, MA, RN
Videos
Best Practices in Care Team Communication Technology: Updates From NCCN 2024
04/06/2024

Featuring Robert Stillman, MA, RN

Featuring Robert Stillman, MA, RN ...
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN,...
04/06/2024
Journal of Clinical Pathways
Anna Halpern, MD
Videos
An Overview of the Benefits and Challenges of Providing Outpatient Oncology Care
04/06/2024

Featuring Anna Halpern, MD

Featuring Anna Halpern, MD
Anna Halpern, MD, discusses her National Comprehensive Cancer Network annual conference session on how to balance inpatient and outpatient oncology care.
Anna Halpern, MD, discusses her National Comprehensive Cancer Network annual conference session on how to balance inpatient and outpatient oncology care.
Anna Halpern, MD, discusses her...
04/06/2024
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP March/April 2024

Current Issue

April 2024
Volume 10
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement